# Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO

> **NCT06792643** · PHASE2 · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 50 (estimated)

## Conditions studied

- Cardiogenic Shock
- Extracorporeal Membrane Oxygenation Complication
- Platelet Dysfunction

## Interventions

- **DRUG:** Cangrelor

## Key facts

- **NCT ID:** NCT06792643
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2025-10-29
- **Final completion:** 2025-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06792643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06792643, "Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06792643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*